Clinical features and multidimensional prognostic model of EGFR-TKI acquired resistance in NSCLC patients with or without brain metastases
- DOI
- 10.1016/j.ctarc.2026.101442
- Published
- 2026
- Container
- Cancer Treatment and Research Communications
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.ctarc.2026.101442,
title = {Clinical features and multidimensional prognostic model of EGFR-TKI acquired resistance in NSCLC patients with or without brain metastases},
author = {Yuting Wang and Xia Li and Zhifang Mao and Qinglin Shen},
year = {2026},
journal = {Cancer Treatment and Research Communications},
doi = {10.1016/j.ctarc.2026.101442},
url = {https://doi.org/10.1016/j.ctarc.2026.101442}
}RIS
TY - JOUR TI - Clinical features and multidimensional prognostic model of EGFR-TKI acquired resistance in NSCLC patients with or without brain metastases AU - Yuting Wang AU - Xia Li AU - Zhifang Mao AU - Qinglin Shen PY - 2026 JO - Cancer Treatment and Research Communications DO - 10.1016/j.ctarc.2026.101442 UR - https://doi.org/10.1016/j.ctarc.2026.101442 ER -
APA
Wang, Y., Li, X., Mao, Z., & Shen, Q. (2026). Clinical features and multidimensional prognostic model of EGFR-TKI acquired resistance in NSCLC patients with or without brain metastases. Cancer Treatment and Research Communications. https://doi.org/10.1016/j.ctarc.2026.101442
Source records
- crossref · retrieved 2026-09-26T03:51:17.715Z